HIV Mutation Detail Information

> A502F Search Result


Mutation Information
Mutation Site A502F
Mutation Type Amino acid level
Gene/Protein/Region Type RT
Relevant Drug NNRTIs;efavirenz (EFV)
Literature Information
PubMed PMID 32183488
Published Year 2020
Journal Molecules (Basel, Switzerland)
Title 2-(Arylamino)-6-(trifluoromethyl)nicotinic Acid Derivatives: New HIV-1 RT Dual Inhibitors Active on Viral Replication.
Author Corona A,Onnis V,Del Vecchio C,Esposito F,Cheng YC,Tramontano E
Evidence Besides, both compounds were tested also on RTs mutated in two amino acid residues within the RNase H domain, Q475A and A502F, part of conserved regions of RNase H domain, that have been shown to be involved in the binding of RNase H inhibitors into a pocket close to the RNase H catalytic site but acting as allosteric RNase H inhibitors.

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation